Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Medtronic
US Department of Justice
Harvard Business School
Julphar
Federal Trade Commission
AstraZeneca
Daiichi Sankyo
Mallinckrodt
Dow

Generated: January 22, 2018

DrugPatentWatch Database Preview

S.A.S.-500 Drug Profile

« Back to Dashboard

When do S.a.s.-500 patents expire, and when can generic versions of S.a.s.-500 launch?

S.a.s.-500 is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in S.A.S.-500 is sulfasalazine. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

US Patents and Regulatory Information for S.A.S.-500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay S.A.S.-500 sulfasalazine TABLET;ORAL 083450-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Mallinckrodt
Federal Trade Commission
Teva
Baxter
Dow
Cerilliant
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot